Anlotinib Hydrochloride

Related products

• 
  API

  Liraglutide

  CAS:204656-20-2
  Status:DMF, TGA, NMPA, WC
  Indications:Endocrine, nutritional, and metabolic diseases

• 
  API

  Pegcetacoplan

  CAS:2019171-69-6

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  API

  Eptifibatide

  CAS:188627-80-7

  Status:DMF, NMPA, WC

  Indications:Diseases of the circulatory system
• 
  API

  Tirzepatide

  CAS:2023788-19-2

  Status:DMF, NMPA

  Indications:Endocrine, nutritional, and metabolic diseases